Analysts at Needham & Company LLC initiated coverage on shares of Ocular Therapeutix (NASDAQ:OCUL – Get Free Report) in a ...

Needham downgraded dental product makers Dentsply Sirona (NASDAQ:XRAY) and ZimVie (NASDAQ:ZIMV) to Hold from Buy on Thursday, ...

Fintel reports that on March 13, 2025, Needham downgraded their outlook for ZimVie (NasdaqGS:ZIMV) from Buy to Hold. Analyst ...

Equities researchers at Needham & Company LLC initiated coverage on shares of Backblaze (NASDAQ:BLZE – Get Free Report) in a note issued to investors on Tuesday, MarketBeat reports. The brokerage set ...

Needham&Company reaffirmed its Buy rating on Amplitude shares following the company's investor day, highlighting innovations in AI, platform adoption, and enterprise growth.

In a report released today, Kyle Peterson from Needham maintained a Hold rating on Cardlytics (CDLX – Research Report). The company’s shares ...

In a report released today, Kyle Peterson from Needham maintained a Hold rating on TriNet Group (TNET – Research Report). The company’s shares ...

Needham analyst Laura Martin raised the firm’s price target on FuboTV (FUBO) to $3.50 from $2 and keeps a Buy rating on the ...

Needham Aggressive Growth Fund earns an Above Average Process Pillar rating. The most significant contributor to the rating is the fund's impressive long-term risk-adjusted performance. This can ...

Needham Growth Fund earns an Above Average Process Pillar rating. The largest contributor to the rating is the firm's retention rate of the firm's portfolio managers, which is 100% over the ...

Needham downgraded Dentsply Sirona and ZimVie to Hold from Buy, citing a lack of near-term catalysts and continued weakness in the dental market.